Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
Sobha SivaprasadLaser and Retinal Research Unit, King’s College Hospital, UKAbstract: Age-related macular degeneration (AMD) is responsible for more than half the blind registration in the United Kingdom. Retinal manifestations of AMD can be categorized as either atrophic or neovascula...
Saved in:
Main Author: | Sobha Sivaprasad |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/e50ab6501f274d3192e46e87d9713aef |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
by: Sobha Sivaprasad, et al.
Published: (2008) -
Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany
by: Nikolaus Feucht, et al.
Published: (2008) -
Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases
by: Roopa Vemala, et al.
Published: (2010) -
Treatment of neovascular age-related macular degeneration in patients with diabetes
by: Michael Cummings, et al.
Published: (2008) -
Treatment of neovascular age-related macular degeneration: Current therapies
by: Albert J Augustin, et al.
Published: (2009)